We are monitoring the impact of COVID-19 on Europe Autoinjectors Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5830
Share on
Share on

Europe Autoinjectors Market Research Report – Segmented By Product, Usability, Manufacturing Design, Technology, Application, Distribution Channels, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 5830
Pages: 145

Europe Autoinjectors Market Size (2021 to 2026)

The Europe Autoinjectors Market size is estimated to be growing at a CAGR of 16.32% from 2021 to 2026. As a result, the size of the market is forecasted to be worth USD 1.76 billion by 2026 from USD 0.83 billion in 2021.

The European autoinjectors market is primarily driven by factors such as an increase in the prevalence of chronic diseases, the growth of the biologics industry, the approval of self-injecting devices such as pen injectors, enhanced technology, and patient compliance. An increase in serving to regulate the action of medicines and an increase in the incidence of anaphylaxis. Other factors such as regulatory approval for various devices, such as protected syringes, prefilled syringes, and auto disabled syringes, are expected to fuel the autoinjectors market growth in the European region.

Increasing patient awareness, potential reimbursements, and government financing and design innovations are further propelling the market forward. In addition, the authorities of EU governments to use biologics expiration dates to promote demand for biosimilars creates more market opportunities. Furthermore, autoinjectors are more effective and less uncomfortable than syringes. They allow for greater control and accurate medication administration than manual injection.

On the other hand, the novel medication formulations and developments in drug delivery systems and regulatory approval are expected to offer additional growth possibilities to the EU autoinjectors market. As a result, staying on top of trends is critical for decision-makers to maximize the available opportunity. Furthermore, the growing elderly population contributes to the growth of the European autoinjectors market during the forecast period. 

However, alternative ways to medicine administration, such as speech and application, safety issues, and the risk of blood injections, are expected to impede the EU autoinjectors market expansion. In addition, exorbitant prices and a lack of understanding about self-medication, as well as rigorous rules and hazards associated with autoinjectors, are further expected to hamper the growth rate of the market. Furthermore, the lack of proper action in having a skill for using autoinjectors and the development of autoinjectors for many drugs with sticky and semi-fluid consistency are a few of the notable challenges that the market faces. Alternatives drug delivery modes, such as epinephrine nasal sprays and oral diabetic agents, and the oral injectors are expected to restrict the expansion rate of the market.

This research report on the European Autoinjectors market has been segmented & sub-segmented market into the following categories:

By Product:  

  • Fillable Autoinjectors
  • Prefilled Autoinjectors

By Usability: 

  • Disposable Autoinjectors
  • Reusable Autoinjectors

By Manufacturing Design: 

  • Standardized Autoinjectors
  • Customized Autoinjectors

By Technology: 

  • Automated Autoinjectors
  • Manual Autoinjectors

By Application: 

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European region is always an essential part of the global economy. The growth of the European autoinjectors market is attributed to the rising number of diabetic patients and the growing population. In addition, growing awareness of people’s on autoinjectors and their adoption of sedentary lifestyles are two significant factors driving the autoinjectors market in emerging countries. Growing availability of funding and government clearance for research and development is beneficial for manufacturing companies, supporting the autoinjectors market expansion in the forecast period in the European region. The countries in the region such as Germany, UK, Italy, France, and Spain significantly contribute to the European regional market growth.

The German autoinjectors market is predicted to lead the European market during the forecast period due to numerous factors such as increased awareness and favorable reimbursement policies, and growing healthcare spending. Furthermore, the presence of market leaders in Germany has a significant impact on market growth. In addition, the German autoinjectors market is being fuelled by innovation in drug delivery systems, increased usage of autoinjectors, diabetes and cancer, and favorable government policies.

KEY MARKET PLAYERS:

Companies such as Mylan N.V., Pfizer, Inc., Bayer AG, Becton, Dickinson and Company, Novartis AG, Biogen Idec, Inc., Janssen North America Services, LLC, Sanofi, Unilife Corporation, and Eli Lilly and Company are some of the prominent companies in the European Autoinjectors Market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fillable Autoinjectors          

                                5.1.3 Prefilled Autoinjectors       

                                5.1.4 Y-o-Y Growth Analysis, By Product               

                                5.1.5 Market Attractiveness Analysis, By Product             

                                5.1.6 Market Share Analysis, By Product               

                5.2 Usability                       

                                5.2.1 Introduction           

                                5.2.2 Disposable Autoinjectors  

                                5.2.3 Reusable Autoinjectors     

                                5.2.4 Y-o-Y Growth Analysis, By Usability              

                                5.2.5 Market Attractiveness Analysis, By Usability            

                                5.2.6 Market Share Analysis, By Usability              

                5.3 Manufacturing Design                           

                                5.3.1 Introduction           

                                5.3.2 Standardized Autoinjectors             

                                5.3.3 Customized Autoinjectors

                                5.3.4 Y-o-Y Growth Analysis, By Manufacturing Design   

                                5.3.5 Market Attractiveness Analysis, By Manufacturing Design 

                                5.3.6 Market Share Analysis, By Manufacturing Design  

                5.4 Technology                 

                                5.4.1 Introduction           

                                5.4.2 Automated Autoinjectors

                                5.4.3 Manual Autoinjectors        

                                5.4.4 Y-o-Y Growth Analysis, By Technology        

                                5.4.5 Market Attractiveness Analysis, By Technology      

                                5.4.6 Market Share Analysis, By Technology        

                5.5 Application                 

                                5.5.1 Introduction           

                                5.5.2 Anaphylaxis            

                                5.5.3 Multiple Sclerosis 

                                5.5.4 Rheumatoid Arthritis          

                                5.5.5 Y-o-Y Growth Analysis, By Application         

                                5.5.6 Market Attractiveness Analysis, By Application       

                                5.5.7 Market Share Analysis, By Application        

                5.6 Distribution Channels                             

                                5.6.1 Introduction           

                                5.6.2 Hospitals  

                                5.6.3 Retail         

                                5.6.4 Online Pharmacies               

                                5.6.5 Others      

                                5.6.6 Y-o-Y Growth Analysis, By Distribution Channels    

                                5.6.7 Market Attractiveness Analysis, By Distribution Channels  

                                5.6.8 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Usability

                                                6.1.3.4 By Manufacturing Design

                                                6.1.3.5 By Technology

                                                6.1.3.6 By Application

                                                6.1.3.7 By Distribution Channels

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Usability

                                                6.1.4.4 By Manufacturing Design

                                                6.1.4.5 By Technology

                                                6.1.4.6 By Application

                                                6.1.4.7 By Distribution Channels

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Usability

                                                6.1.5.4 By Manufacturing Design

                                                6.1.5.5 By Technology

                                                6.1.5.6 By Application

                                                6.1.5.7 By Distribution Channels

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Mylan N.V.                 

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer, Inc.,                 

                8.3 Bayer AG                     

                8.4 Becton, Dickinson and Company                       

                8.5 Novartis AG                

                8.6 Biogen Idec, Inc.,                     

                8.7 Janssen Global Services                        

                8.8 Sanofi                           

                8.9 Eli Lilly and Company                              

                8.10 Unilife Corporation                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Technology  with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  2. Europe Fillable Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  3. Europe  Prefilled Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  4. Europe Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  5. Europe Disposable Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  6. Europe Reusable Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  7. Europe Autoinjectors Market, By Manufacturing Design , From 2021 to 2026 (USD Billion)
  8. Europe Standardized Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  9. Europe Customized Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  10. Europe Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  11. Europe Automated Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  12. Europe Manual Autoinjectors Market By Region, From 2021 to 2026 (USD Billion)
  13. Europe Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  14. Europe Anaphylaxis Market By Region, From 2021 to 2026 (USD Billion)
  15. Europe Multiple Sclerosis Market By Region, From 2021 to 2026 (USD Billion)
  16. Europe Rheumatoid Arthritis Market By Region, From 2021 to 2026 (USD Billion)
  17. Europe Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  18. Europe Hospitals Market By Region, From 2021 to 2026 (USD Billion)
  19. Europe  Retail Market By Region, From 2021 to 2026 (USD Billion)
  20. Europe Online Pharmacies Market By Region, From 2021 to 2026 (USD Billion)
  21. Europe Others Market By Region, From 2021 to 2026 (USD Billion)
  22. U.K. Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  23. U.K. Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  24. U.K. Autoinjectors Market, By Manufacturing Design , From 2021 to 2026 (USD Billion)
  25. U.K. Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  26. U.K. Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  27. U.K. Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  28. Germany Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  29. Germany Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  30. Germany Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  31. Germany Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  32. Germany Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  33. Germany Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  34. France Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  35. France Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  36. France Autoinjectors Market, By Manufacturing Design , From 2021 to 2026 (USD Billion)
  37. France Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  38. France Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  39. France Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  40. Italy Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  41. Italy Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  42. Italy Autoinjectors Market, By Manufacturing Design, From 2021 to 2026 (USD Billion)
  43. Italy Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  44. Italy Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  45. Italy Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  46. Spain Autoinjectors Market, By Product, From 2021 to 2026 (USD Billion)
  47. Spain Autoinjectors Market, By Usability, From 2021 to 2026 (USD Billion)
  48. Spain Autoinjectors Market, By Manufacturing Design , From 2021 to 2026 (USD Billion)
  49. Spain Autoinjectors Market, By Technology, From 2021 to 2026 (USD Billion)
  50. Spain Autoinjectors Market, By Application, From 2021 to 2026 (USD Billion)
  51. Spain Autoinjectors Market, By Distribution Channels, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample